The report provides an in-depth analysis of market trends, macro-economic indicators, and governing factors.
Portland, OR -- (SBWIRE) -- 09/19/2017 -- Therapeutic stent is a metallic or a polymer tube implanted into the lumen of blood vessels or ducts to keep the passage open. A stent implant is commonly used for the treatment of cardiac abnormalities such as blocked blood vessels. In addition, stents are implanted in the esophagus to facilitate the passage of food & beverages in patients suffering from esophageal cancer.
Access to the full summary: https://www.alliedmarketresearch.com/therapeutic-stents-market
The global therapeutic stents market is expected to witness rapid growth due to rise in geriatric population (majorly of the people highly susceptible to strokes and require stent implant for treatment), technological advancements in stents, increased adoption rate of these devices, and increased risk of restenosis in patients undergoing angioplasty. In addition, unhealthy diet habits and lack of necessary physical activity lead to the development of cardiovascular diseases, which increase the need for percutaneous coronary interventions. Conversely, high specificity of stents, exorbitant cost of stent implant procedures, and stringent government regulations are the key factors that hamper the market growth.
The key players operating in the therapeutic stents market include Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, C.R. Bard, Inc., Elixir Medical Corporation, Medtronic plc, Microport Scientific Corporation, STENTYS SA, and Terumo Corporation.
Get sample PDF: https://www.alliedmarketresearch.com/request-toc-and-sample/4056
Therapeutic Stents Market Key Segments:
- Drug-Eluting Stents (DES)
- Bare-Metal Coronary Stents
- Bioabsorbable Stent
- Synthetic Grafts
- Vena Cava Filters
- Metallic Biomaterials
- Polymers Biomaterials
- Natural Biomaterials
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- South Africa
- Saudi Arabia
- Rest of LAMEA